The effect of phototherapy on progression to tumors in patients with patch and plaque stage of mycosis fungoides

References

• Carter J, Zug KA. Phototherapy for cutaneous T-cell lymphoma: online survey and literature review. J Am Acad Dermatol. 2009;60:39–50.
   PubMed Web of Science ®Google Scholar
• Gilchrest BA, Parrish JA, Tanenbaum L, et al. Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer. 1976;38:683–689.
   PubMed Web of Science ®Google Scholar
• Gettler SL, Fung MA. Efficacy of treatments for mycosis fungoides and Sezary syndrome: nationwide survey responses. Dermatol Online J. 2005;11:6.
   PubMedGoogle Scholar
• Ramsay DL, Lish KM, Yalowitz CB, et al. Ultraviolet-B phototherapy for early-stage cutaneous T-cell lymphoma. Arch Dermatol. 1992;128:931–933.
   PubMed Web of Science ®Google Scholar
• Olsen EA, Hodak E, Anderson T, et al. Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: a consensus statement of the United States Cutaneous Lymphoma Consortium. J Am Acad Dermatol. 2016;74:27–58.
   PubMed Web of Science ®Google Scholar
• Hearn RM, Kerr AC, Rahim KF, et al. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy. Br J Dermatol. 2008;159:931–935.
   PubMed Web of Science ®Google Scholar
• Lee E, Koo J, Berger T. UVB phototherapy and skin cancer risk: a review of the literature. Int J Dermatol. 2005;44:355–360.
   PubMed Web of Science ®Google Scholar
• Stern RS, Liebman EJ, Vakeva L. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study. J Natl Cancer Inst. 1998;90:1278.
   PubMed Web of Science ®Google Scholar
• Stern RS, Laird N, Melski J, et al. Cutaneous squamous-cell carcinoma in patients treated with PUVA. New England J Med. 1984;310:1156–1161.
   PubMed Web of Science ®Google Scholar
• Morison WL, Baughman RD, Day RM, et al. Consensus workshop on the toxic effects of long-term PUVA therapy. Arch Dermatol. 1998;134:595–598.
   PubMed Web of Science ®Google Scholar
• Chuang TY, Heinrich LA, Schultz MD, et al. PUVA and skin cancer. A historical cohort study on 492 patients. J Am Acad Dermatol. 1992;26(2 Pt 1):173–177.
   Web of Science ®Google Scholar
• Stern RS, Nichols KT, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study. New England J Med. 1997;336:1041.
   PubMed Web of Science ®Google Scholar
• Stern RS. PUVA Follow up Study. The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol. 2001;44:755–761.
   PubMed Web of Science ®Google Scholar
• Querfeld C, Rosen ST, Kuzel TM, et al. Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy. Arch Dermatol. 2005;141:305–311.
   PubMed Web of Science ®Google Scholar
• Kim YH, Liu HL, Mraz-Gernhard S, et al. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression. Arch Dermatol. 2003;139:857–866.
   PubMed Web of Science ®Google Scholar
• McGregor JM, Crook T, Fraser-Andrews EA, et al. Spectrum of p53 gene mutations suggests a possible role for ultraviolet radiation in the pathogenesis of advanced cutaneous lymphomas. J Invest Dermatol. 1999;112:317–321.
   PubMed Web of Science ®Google Scholar
• Scarisbrick JJ, Woolford AJ, Russell-Jones R, et al. Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN. Blood. 2000;195:2937–2942.
   PubMed Web of Science ®Google Scholar
• Navas IC, Ortiz-Romero PL, Villuendas R, et al. p16(INK4a) gene alterations are frequent in lesions of mycosis fungoides. Am J Pathol. 2000;156:1565–1572.
   PubMed Web of Science ®Google Scholar
• Sommer VH, Clemmensen OJ, Nielsen O, et al. In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3. Leukemia. 2004;18:1288–1295.
   PubMed Web of Science ®Google Scholar
• Tracey L, Villuendas R, Dotor AM, et al. Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study. Blood. 2003;102:1042.
   PubMed Web of Science ®Google Scholar
• El-Domyati M, Moftah NH, Nasif GA, et al. Evaluation of apoptosis regulatory proteins in response to PUVA therapy for psoriasis. Photodermatol Photoimmunol Photomed. 2013;29:18–26.
   PubMed Web of Science ®Google Scholar
• Kohyama S, Morimoto Y, Nakai K, et al. Effectiveness of narrow-band ultraviolet-B phototherapy for prevention of intimal hyperplasia in a rat carotid balloon injury model. Lasers Surg Med. 2007;39:659–666.
   PubMed Web of Science ®Google Scholar
• Weichenthal M, Schwarz T. Phototherapy: how does UV work?. Photodermatol Photoimmunol Photomed. 2005;21:260–266.
   PubMed Web of Science ®Google Scholar
• Ozawa M, Ferenczi K, Kikuchi T, et al. 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med. 1999;189:711–718.
   PubMed Web of Science ®Google Scholar
• Benjamin CL, Ananthaswamy HN. p53 and the pathogenesis of skin cancer. Toxicol Appl Pharmacol. 2007;224:241–248.
   PubMed Web of Science ®Google Scholar
• Dumaz N, van Kranen HJ, de Vries A, et al. The role of UV-B light in skin carcinogenesis through the analysis of p53 mutations in squamous cell carcinomas of hairless mice. Carcinogenesis. 1997;18:897–904.
   PubMed Web of Science ®Google Scholar
• Jonason AS, Kunala S, Price GJ, et al. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci USA. 1996;93:14025–14029.
   PubMed Web of Science ®Google Scholar
• Stahl PL, Stranneheim H, Asplund A, et al. Sun-induced nonsynonymous p53 mutations are extensively accumulated and tolerated in normal appearing human skin. J Invest Dermatol. 2011;131:504–508.
   PubMed Web of Science ®Google Scholar